©2024 Stanford Medicine
Hypertonic Saline as Therapy for Pediatric Concussion
Not Recruiting
Trial ID: NCT01612494
Purpose
This single center, blinded, randomized controlled trial evaluated the use of hypertonic saline versus normal saline as therapy for the symptoms of pediatric concussion post head injury.
The study hypothesis was that hypertonic saline would improve symptoms of pediatric concussion following head injury as measured on the self-reported Wong Baker Faces Pain Scale as compared to normal saline.
The null hypothesis was that there would be no difference in change of reported pain in either group.
Official Title
Hypertonic Saline as Therapy for Pediatric Concussion: A Randomized Controlled Trial in the Emergency Department
Stanford Investigator(s)
Angela K. Lumba-Brown
Clinical Associate Professor, Emergency Medicine Clinical Associate Professor (By courtesy), Neurosurgery Clinical Associate Professor, Pediatrics
Eligibility
Inclusion Criteria:
* 4-17 years old
* consent obtained
* pain as a symptom of concussion
* head CT negative for intracranial pathology
Exclusion Criteria:
* younger than 4 years or older than 17 years
* multi trauma
* cardiac, neuro, renal history of disease
* seizure
* narcotic, drug use
* pregnancy
* head CT with traumatic intracranial pathology
* no consent
Intervention(s):
drug: Hypertonic Saline
other: Normal Saline
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305